article thumbnail

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

article thumbnail

Join us at the Global Clinical Trials Connect 2018, 25-26 April, London

mHealth Insight

On Thursday the 26th April 2018 we’ll be presenting on Mobile First Clinical Trial Design at the Global Clinical Trials Connect 2018 Conference in London. Max Woolley, R&D Manager, Pre-Clinical Lead, Drug Delivery, Device Design & Development, Renishaw. Cases of failures, cost and delay are high.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

Billed as the first and largest telemedicine company in the United States, Teladoc Health was launched in 2002 and has acquired companies such as BetterHelp in 2015, Best Doctors in 2017, and Advance Medical in 2018. In 2018, Teladoc acquired Advance Medical, a provider of home health care services.

article thumbnail

Leveraging T2D Drugs to improve T1D Therapy

Insulin Nation

In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. This was the first research ( release ) on using this Type 2 approved drug for T1D treatment and there were larger confirmatory studies ( release ) in 2016 and 2018.

article thumbnail

Metformin Myths and Misconceptions

DrKumo Remote Patient Monitoring

Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. 2018; 137:422–424. Cardiovascular diabetology, 18(1), 96. and Lang, C.

article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

In the past three years alone, the Company has grown exponentially, more than tripling its annual revenue, growing its employee base to 39, a 5x increase since 2018, and expanding its extensive client list to 125+ partners across the U.S. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

article thumbnail

Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business

Healthcare IT Today

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A Source: Markets and Markets “Digital Pathology Market, Global Forecast to 2025”; Signify Research “Digital Pathology – World – 2018”.